Good Medicine Podcast AI & Machine Learning | Dr. Chris Gibson
May 27, 2025
Dr. Chris Gibson, Co-Founder and CEO of Recursion Pharmaceuticals and bioengineering PhD holder, shares his journey from research to revolutionizing drug discovery. He discusses the exciting intersection of AI and biology, emphasizing how machine learning can transform healthcare. The conversation also covers the integration of advanced tech in clinical trials and the need for healthcare to shift from treatment to prevention. With insights into data-driven innovation, it paints an optimistic picture for the future of medicine.
AI Snips
Chapters
Transcript
Episode notes
Chris Gibson's Early Inspiration
- Chris Gibson was fascinated with how things work from a young age and initially wanted to be an astronaut.
- Passing the height limit led him away from that dream toward bioengineering and eventually founding Recursion Pharmaceuticals.
Pivot from Medicine to Entrepreneurship
- During grad school, Chris shifted from medicine to entrepreneurship after success using machine learning on cell images.
- He took a leave of absence from med school in 2013 to pursue what became Recursion Pharmaceuticals.
Using Computer Vision to Decode Biology
- The core idea was leveraging computer vision on massive biological image datasets to decode biology.
- This enabled identifying new drug uses by analyzing cellular structure and function relationships.